BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34155909)

  • 1. Hypermetabolic Cerebellar Connectome in Alzheimer's Disease.
    Gupta V; Booth S; Ko JH
    Brain Connect; 2023 Aug; 13(6):356-366. PubMed ID: 34155909
    [No Abstract]   [Full Text] [Related]  

  • 2. The Association of Glucose Metabolism and Eigenvector Centrality in Alzheimer's Disease.
    Adriaanse SM; Wink AM; Tijms BM; Ossenkoppele R; Verfaillie SC; Lammertsma AA; Boellaard R; Scheltens P; van Berckel BN; Barkhof F
    Brain Connect; 2016 Feb; 6(1):1-8. PubMed ID: 26414628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.
    Küntzelmann A; Guenther T; Haberkorn U; Essig M; Giesel F; Henze R; Schroeter ML; Schröder J; Schönknecht P
    Neurosci Lett; 2013 Feb; 534():12-7. PubMed ID: 23182881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.
    Förster S; Yousefi BH; Wester HJ; Klupp E; Rominger A; Förstl H; Kurz A; Grimmer T; Drzezga A
    Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1927-36. PubMed ID: 22926714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Network Topology of Alzheimer's Disease and Dementia with Lewy Bodies Generated Using Fluorodeoxyglucose Positron Emission Tomography.
    Imai M; Tanaka M; Sakata M; Wagatsuma K; Tago T; Toyohara J; Sengoku R; Nishina Y; Kanemaru K; Ishibashi K; Murayama S; Ishii K
    J Alzheimers Dis; 2020; 73(1):197-207. PubMed ID: 31771066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer's disease.
    Kawachi T; Ishii K; Sakamoto S; Sasaki M; Mori T; Yamashita F; Matsuda H; Mori E
    Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):801-9. PubMed ID: 16550383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Alzheimer and Lewy Body Disease Pathologies on Brain Metabolism.
    Lee YG; Jeon S; Park M; Kang SW; Yoon SH; Baik K; Lee PH; Sohn YH; Ye BS;
    Ann Neurol; 2022 Jun; 91(6):853-863. PubMed ID: 35307860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.
    Khosravi M; Peter J; Wintering NA; Serruya M; Shamchi SP; Werner TJ; Alavi A; Newberg AB
    J Alzheimers Dis; 2019; 70(4):1197-1207. PubMed ID: 31322568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease.
    Musiek ES; Chen Y; Korczykowski M; Saboury B; Martinez PM; Reddin JS; Alavi A; Kimberg DY; Wolk DA; Julin P; Newberg AB; Arnold SE; Detre JA
    Alzheimers Dement; 2012 Jan; 8(1):51-9. PubMed ID: 22018493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression based on FDG PET data.
    Sörensen A; Blazhenets G; Rücker G; Schiller F; Meyer PT; Frings L;
    Neuroimage Clin; 2019; 21():101637. PubMed ID: 30553760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease.
    Li Y; Rinne JO; Mosconi L; Pirraglia E; Rusinek H; DeSanti S; Kemppainen N; Någren K; Kim BC; Tsui W; de Leon MJ
    Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2169-81. PubMed ID: 18566819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypometabolic and hypermetabolic brain regions in patients with ALS-FTD show distinct patterns of grey and white matter degeneration: A pilot multimodal neuroimaging study.
    Rajagopalan V; Pioro EP
    Eur J Radiol; 2023 Jan; 158():110616. PubMed ID: 36493498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjusted scaling of FDG positron emission tomography images for statistical evaluation in patients with suspected Alzheimer's disease.
    Buchert R; Wilke F; Chakrabarti B; Martin B; Brenner W; Mester J; Clausen M
    J Neuroimaging; 2005 Oct; 15(4):348-55. PubMed ID: 16254400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual brain metabolic connectome indicator based on Kullback-Leibler Divergence Similarity Estimation predicts progression from mild cognitive impairment to Alzheimer's dementia.
    Wang M; Jiang J; Yan Z; Alberts I; Ge J; Zhang H; Zuo C; Yu J; Rominger A; Shi K;
    Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2753-2764. PubMed ID: 32318784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain metabolic connectome classify mild cognitive impairment into Alzheimer's dementia
    Wang M; Yan Z; Jiang J
    Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():32-35. PubMed ID: 31945838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and prognosis of prodromal Alzheimer's disease as assessed by magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography in a community: reanalysis from the Osaki-Tajiri Project.
    Meguro K; Akanuma K; Meguro M; Yamaguchi S; Ishii H; Tashiro M
    Psychogeriatrics; 2016 Mar; 16(2):116-20. PubMed ID: 26114837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Clinical Value of Multiparametric PET in the Prediction of Alzheimer's Disease Progression.
    Chen X; Zhou Y; Wang R; Cao H; Reid S; Gao R; Han D;
    PLoS One; 2016; 11(5):e0154406. PubMed ID: 27183116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiscale deep neural network based analysis of FDG-PET images for the early diagnosis of Alzheimer's disease.
    Lu D; Popuri K; Ding GW; Balachandar R; Beg MF;
    Med Image Anal; 2018 May; 46():26-34. PubMed ID: 29502031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's Disease Is Associated with Increased Network Assortativity: Evidence from Metabolic Connectivity.
    Khokhar SK; Kumar M; Kumar S; Manae T; Thanissery N; Ramakrishnan S; Arshad F; Nagaraj C; Mangalore S; Alladi S; Gandhi TK; Bharath RD
    Brain Connect; 2023 Dec; 13(10):610-620. PubMed ID: 37930734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.